He is also a member of the Steering Committee of the CIBER Pathophysiology of Obesity and Nutrition (CIBERobn) of the Carlos III Health Institute (Ministry of Science and Innovation, Government of Spain), principal investigator of the Cardiovascular Risk, Nutrition and Aging Group (Consolidated Group of the Generalitat, 2017SGR1717) of Area 2 Biopathology and respiratory, cardiovascular and renal bioengineering, of IDIBAPS-CELLEX and member of the Advisory Committee of the European Foundation for Alcohol Research (ERAB) of the European Union. Within the framework of CIBERobn he is a main investigator of the group.
He is the coordinator of the PREDIMED study, the largest multicenter Mediterranean Diet intervention study ever conducted in the world (7447 participants with high cardiovascular ris, average follow-up of 5 years) and in which research groups from all over Spain have participated. In addition, it participates and collaborates in several multicenter randomized Mediterranean Diet nutritional intervention trials with patients at risk of cardiovascular disease and cancer, such as the PREDIMED-Plus Study (6874 participants with Metabolic Syndrome, 6-year follow-up), the SI program randomized intervention trial (1200 adolescents, 6-year follow-up), the IMPACT study (1,200 pregnant women with intrauterine growth retardation), and the MEDCARS cohort study (14,000 workers from SEAT factories).
He has published over 5 books, over 50 book chapters and over 630 original articles in high-impact journals including The New England Journal of Medicine, JAMA, Lancet, Annals of Internal Medicine, Annals of Neurology and American Journal of Clinical Nutrition. He currently maintains a permanent relationship with multiple universities and teams such as Columbia University in New York, Loma Linda University in California, Harvard School of Public Health in Massachusetts, Human Nutrition Research Centre at Tufts University (Massachusetts, USA), Jefferson University (Philadelphia, USA), Ernest Gallo Clinic and Research Center (University of California, San Francisco), University of Oulu (Oulu, Finland), Institut des Vaisseaux et du Sang (Paris), Faculty of Medicine and Dentistry of King’s College (London, UK), Mario Negri Sud (Santa Maria d’Imbaro, Italy), CSIC, Cardiovascular Research Center, Hospital de la Santa Creu i Sant Pau in Barcelona, CNIC in Madrid, and PREDIMED and PREDIMED plus centers throughout Spain.